Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 03-11-2024 | 01-31-2024 | 10-Q | |
| 2 | 01-29-2024 | 10-31-2023 | 10-K |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Oral presentation highlights rational design of EG-70 to address challenges faced by other intravesical treatment options, incl...
Wells Fargo analyst Yanan Zhu initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Overweight rating and announces Pri...
Guggenheim analyst Manuel Navas initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Buy rating and announces Price Ta...
UBS analyst Colin Bristow initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Buy rating and announces Price Target o...
The company closed a $200 million oversubscribed private financing, expected to extend cash runway into 2027.
Morgan Stanley analyst Jeffrey Hung initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Overweight rating and announc...
Leerink Partners analyst Mani Foroohar initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Outperform rating and anno...
Shares of AppLovin Corporation (NASDAQ: APP) rose sharply in today’s pre-market trading after the company reported better-than...
U.S. stock futures were higher this morning, with the Dow futures trading higher by around 70 points on Thursday.
